Beijing Science Sun Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Beijing Science Sun Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Beijing Science Sun Pharmaceutical Co Ltd (300485) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.68 Million ≈ $4.20 Million USD) by net assets (CN¥3.43 Billion ≈ $502.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Beijing Science Sun Pharmaceutical Co Ltd (2011–2025)
Cash flow conversion efficiency of Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2025. This chart illustrates how Beijing Science Sun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Beijing Science Sun Pharmaceutical Co Lt for real-time trading data and today's change.
Beijing Science Sun Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Beijing Science Sun Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Beijing Science Sun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Science Sun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Beijing Science Sun Pharmaceutical Co Lt (300485) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grupo Supervielle S.A. B
BA:SUPV
|
0.176x |
|
Bajaj Consumer Care Limited
NSE:BAJAJCON
|
0.105x |
|
Shandong Astro-century Education&Technology Co Ltd
SHE:300654
|
0.024x |
|
Rongcheer Industrial Technology (Suzhou) Co. Ltd. A
SHE:301360
|
N/A |
|
Lucky Film Co Ltd
SHG:600135
|
0.059x |
|
Jiangsu Feymer Technology Co Ltd
SHG:688350
|
0.064x |
|
SAPPI LTD ADR/1 RC 1
F:SPIA
|
0.023x |
|
ShaoYang Victor Hydraulics Co.Ltd
SHE:301079
|
N/A |
Annual Cash Flow Conversion Efficiency for Beijing Science Sun Pharmaceutical Co Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2025. Review how much free cash does Beijing Science Sun Pharmaceutical Co Lt generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.39 Billion ≈ $496.42 Million |
CN¥27.08 Million ≈ $3.96 Million |
0.008x | -80.13% |
| 2024-12-31 | CN¥3.39 Billion ≈ $495.39 Million |
CN¥135.97 Million ≈ $19.90 Million |
0.040x | +556.62% |
| 2023-12-31 | CN¥3.47 Billion ≈ $507.42 Million |
CN¥21.21 Million ≈ $3.10 Million |
0.006x | -81.10% |
| 2022-12-31 | CN¥3.41 Billion ≈ $499.28 Million |
CN¥110.43 Million ≈ $16.16 Million |
0.032x | -42.03% |
| 2021-12-31 | CN¥3.28 Billion ≈ $480.42 Million |
CN¥183.30 Million ≈ $26.82 Million |
0.056x | -39.67% |
| 2020-12-31 | CN¥2.85 Billion ≈ $417.03 Million |
CN¥263.73 Million ≈ $38.59 Million |
0.093x | +45.43% |
| 2019-12-31 | CN¥2.71 Billion ≈ $396.74 Million |
CN¥172.52 Million ≈ $25.25 Million |
0.064x | +10.99% |
| 2018-12-31 | CN¥2.56 Billion ≈ $373.95 Million |
CN¥146.52 Million ≈ $21.44 Million |
0.057x | +22.89% |
| 2017-12-31 | CN¥2.32 Billion ≈ $339.41 Million |
CN¥108.21 Million ≈ $15.83 Million |
0.047x | -54.03% |
| 2016-12-31 | CN¥2.10 Billion ≈ $307.00 Million |
CN¥212.89 Million ≈ $31.15 Million |
0.101x | +12.82% |
| 2015-12-31 | CN¥1.88 Billion ≈ $275.51 Million |
CN¥169.36 Million ≈ $24.78 Million |
0.090x | -72.85% |
| 2014-12-31 | CN¥646.64 Million ≈ $94.62 Million |
CN¥214.23 Million ≈ $31.35 Million |
0.331x | -16.90% |
| 2013-12-31 | CN¥493.71 Million ≈ $72.25 Million |
CN¥196.82 Million ≈ $28.80 Million |
0.399x | -5.55% |
| 2012-12-31 | CN¥359.96 Million ≈ $52.67 Million |
CN¥151.93 Million ≈ $22.23 Million |
0.422x | +35.50% |
| 2011-12-31 | CN¥247.37 Million ≈ $36.20 Million |
CN¥77.06 Million ≈ $11.28 Million |
0.312x | -- |
About Beijing Science Sun Pharmaceutical Co Ltd
Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of injections in China. The company offers products for cardiovascular, cerebrovascular, immunomodulation, and nervous systems, and other drugs. It is also involved in raw materials, solid oral preparations, and health products; extraction of traditional Chinese me… Read more